UnitedHealth Group Financial Statements (UNH)
|
|
|
|
Report date
|
|
|
01.03.2021 |
15.02.2022 |
31.12.2022 |
24.02.2023 |
31.12.2023 |
|
04.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
255 639 |
285 273 |
324 162 |
322 132 |
371 622 |
|
400 291 |
|
Operating Income, bln rub |
|
|
22 405 |
23 970 |
28 435 |
28 435 |
32 358 |
|
33 222 |
|
EBITDA, bln rub |
? |
|
25 296 |
27 073 |
31 316 |
31 835 |
36 330 |
|
23 164 |
|
Net profit, bln rub |
? |
|
15 403 |
17 285 |
20 120 |
20 120 |
22 381 |
|
14 917 |
|
|
OCF, bln rub |
? |
|
22 174 |
22 343 |
26 206 |
26 206 |
29 068 |
|
35 780 |
|
CAPEX, bln rub |
? |
|
2 051 |
2 454 |
2 802 |
2 802 |
3 386 |
|
3 578 |
|
FCF, bln rub |
? |
|
20 123 |
19 889 |
23 404 |
23 404 |
25 682 |
|
32 202 |
|
Dividend payout, bln rub
|
|
|
4 584 |
5 280 |
5 991 |
5 991 |
6 761 |
|
7 538 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
Dividend payout ratio, %
|
|
|
29.8% |
30.5% |
29.8% |
29.8% |
30.2% |
|
50.5% |
|
|
OPEX, bln rub |
|
|
44 595 |
45 682 |
84 885 |
51 182 |
339 264 |
|
134 648 |
|
Cost of production, bln rub |
|
|
190 141 |
217 945 |
210 842 |
244 545 |
284 753 |
|
414 563 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
1 663 |
1 660 |
2 092 |
2 092 |
3 246 |
|
7 635 |
|
|
Assets, bln rub |
|
|
197 289 |
212 206 |
245 705 |
245 705 |
278 415 |
|
299 309 |
|
Net Assets, bln rub |
? |
|
65 491 |
71 760 |
0.000 |
77 772 |
88 756 |
|
99 881 |
|
Debt, bln rub |
|
|
43 467 |
46 003 |
57 623 |
57 623 |
67 435 |
|
78 010 |
|
Cash, bln rub |
|
|
19 781 |
23 907 |
55 822 |
27 911 |
29 628 |
|
37 134 |
|
Net debt, bln rub |
|
|
23 686 |
22 096 |
1 801 |
29 712 |
37 807 |
|
40 876 |
|
|
Ordinary share price, rub |
|
|
350.7 |
502.1 |
530.2 |
530.2 |
526.5 |
|
537.0 |
|
Number of ordinary shares, mln |
|
|
946.0 |
943.0 |
950.0 |
934.0 |
928.0 |
|
923.0 |
|
|
Market cap, bln rub |
|
|
331 743 |
473 518 |
503 671 |
495 188 |
488 564 |
|
495 651 |
|
EV, bln rub |
? |
|
355 429 |
495 614 |
505 472 |
524 900 |
526 371 |
|
536 527 |
|
Book value, bln rub |
|
|
-16 702 |
-14 079 |
0 |
-29 981 |
-30 170 |
|
-29 691 |
|
|
EPS, rub |
? |
|
16.3 |
18.3 |
21.2 |
21.5 |
24.1 |
|
16.2 |
|
FCF/share, rub |
|
|
21.3 |
21.1 |
24.6 |
25.1 |
27.7 |
|
34.9 |
|
BV/share, rub |
|
|
-17.7 |
-14.9 |
0.00 |
-32.1 |
-32.5 |
|
-32.2 |
|
|
EBITDA margin, % |
? |
|
9.90% |
9.49% |
9.66% |
9.88% |
9.78% |
|
5.79% |
|
Net margin, % |
? |
|
6.03% |
6.06% |
6.21% |
6.25% |
6.02% |
|
3.73% |
|
FCF yield, % |
? |
|
6.07% |
4.20% |
4.65% |
4.73% |
5.26% |
|
6.50% |
|
ROE, % |
? |
|
23.5% |
24.1% |
|
25.9% |
25.2% |
|
14.9% |
|
ROA, % |
? |
|
7.81% |
8.15% |
8.19% |
8.19% |
8.04% |
|
4.98% |
|
|
P/E |
? |
|
21.5 |
27.4 |
25.0 |
24.6 |
21.8 |
|
33.2 |
|
P/FCF |
|
|
16.5 |
23.8 |
21.5 |
21.2 |
19.0 |
|
15.4 |
|
P/S |
? |
|
1.30 |
1.66 |
1.55 |
1.54 |
1.31 |
|
1.24 |
|
P/BV |
? |
|
-19.9 |
-33.6 |
|
-16.5 |
-16.2 |
|
-16.7 |
|
EV/EBITDA |
? |
|
14.1 |
18.3 |
16.1 |
16.5 |
14.5 |
|
23.2 |
|
Debt/EBITDA |
|
|
0.94 |
0.82 |
0.06 |
0.93 |
1.04 |
|
1.76 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.80% |
0.86% |
0.86% |
0.87% |
0.91% |
|
0.89% |
|
| UnitedHealth Group shareholders |
